Clinical Trial

Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 22, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to determine the prevalence of hepatitis D virus (HDV) and the distribution of the HDV genotype in patients with chronic hepatitis B infection. It will also identify factors related to hepatitis D virus infection, such as characteristics of the study sample, vaccination history, drug use affecting hepatitis, family factors, environment, and lifestyle. This study will be conducted at Tam Anh General Hospital, Bach Mai Hospital and Tam Anh TP. Ho Chi Minh General Hospital. Participants will be interviewed directly through a questionnaire to collect some information related to epidemiological risk factors. A blood sample will also be collected.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-10-09; most recent amendment 2026-06-17.
Status change: Active, Not Recruiting → Recruiting 2026-06-12
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-04-14
Trial Details
NCT Number NCT06638320
Lead Sponsor Tam Anh Research Institute
Conditions Hepatitis Delta With Hepatitis B Carrier State, Chronic Hepatitis b
Enrollment 2,452 participants
Start Date 2024-11-01
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-22